Myriad Genetics (MYGN) Non Operating Income (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Non Operating Income of -$3.4 million for Q1 2026, down 3500.0% YoY from $100000.0 in Q1 2025, and up 59.04% sequentially from -$8.3 million in Q4 2025.
Myriad Genetics (MYGN) Non Operating Income (2009 - 2026) Analysis & Trends
Myriad Genetics has disclosed Non Operating Income across 18 years of filings, most recently posting -$3.4 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 3500.0% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at -$12.7 million (down 746.67% YoY), while the FY2025 annual figure was -$7.9 million, down 818.18% from the prior year.
- Non Operating Income rose to -$3.4 million in Q1 2026, from -$8.3 million in the prior quarter.
- Over the last five years, Non Operating Income for MYGN reached as high as $2.0 million in Q1 2024 and fell as low as -$8.3 million in Q4 2025.
- The 5-year median for Non Operating Income is -$650000.0 (2022), against an average of -$1.0 million.
- Annual changes were most pronounced in 2024 — Non Operating Income jumped 600.0% — and 2026, when it plunged 3500.0%.
- A 5-year view of Non Operating Income shows it stood at -$600000.0 in 2022, then tumbled by 50.0% to -$900000.0 in 2023, then surged by 133.33% to $300000.0 in 2024, then slumped by 2866.67% to -$8.3 million in 2025, then soared by 59.04% to -$3.4 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$3.4 million, -$8.3 million, and $400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 9.60 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -4.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -8.30 Mn |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -700,000.00 |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | -2.40 Mn |
| Mar 31, 2023 | -400,000.00 |
| Dec 31, 2022 | -600,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 120.60 Mn |
| Jun 30, 2021 | 18.80 Mn |
| Mar 31, 2021 | -2.90 Mn |